Statins and Risk of Venous Thromboembolic Diseases: A Two-Sample Mendelian Randomization Study

Xiao-Shan Ma,Jing Sun,Ren Geng,Yao Zhao,Wan-Zhen Xu,Yuan-Hao Liu,Yi-Ning Jiang,Yun-Qian Li
DOI: https://doi.org/10.1016/j.numecd.2023.02.023
2023-03-05
Abstract:Background and aims In observational studies, statins have been suggested to have protective effects on venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), we performed a two-sample mendelian randomization (MR) analysis to determine whether these associations were causal. Methods and results Data on the single nucleotide polymorphisms (SNPs) related to statin medication were obtained from the FinnGen study, and data for VTE, PE and DVT of lower extremities (LEDVT) were from the UK Biobank study, respectively. Inverse variance weighted (IVW) method was used as the principal analysis of MR, and sensitivity analysis was performed to detect horizontal pleiotropy and heterogeneity. MR estimates showed an inverse causal association between statin medication and the risk of VTE (odds ratio [OR]: 0.999, 95% CI: 0.998–1.000, P = 0.004), PE (OR: 0.999, 95% CI: 0.999–1.000, P = 0.011) and LEDVT (OR: 0.999, 95% CI: 0.999–1.000, P = 0.008). Conclusion Our findings provide direct evidence that statins might decrease the risk of VTE, PE and LEDVT in agreement with observational studies. The specific mechanism of statin therapy for venous thromboembolism needs to be further studied.
cardiac & cardiovascular systems,endocrinology & metabolism,nutrition & dietetics
What problem does this paper attempt to address?